Abstract
The difficulties in diagnosing pleural mesothelioma, both clinically and histopathologically, are documented by our experiences with this rare tumour during an 18-year-period. A rising incidence of pleural mesothelioma is reported in the literature, which is suspected to be caused by the increasing use of asbestos. This increase is not represented in a non-industrialized area. The heterogenous treatment reported in cases of malignant pleural mesothelioma illustrates the poor results achieved hitherto. Now treatment with either combination chemotherapy or radioactive drugs is recommended.